rs121918767
Variant summary
Our verdict is Pathogenic. Variant got 17 ACMG points: 17P and 0B. PM1PM2PM5PP2PP3_ModeratePP5_Very_Strong
The NM_001165963.4(SCN1A):c.523G>A(p.Ala175Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A175V) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001165963.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 17 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN1A | ENST00000674923.1 | c.523G>A | p.Ala175Thr | missense_variant | Exon 7 of 29 | NM_001165963.4 | ENSP00000501589.1 | |||
SCN1A | ENST00000303395.9 | c.523G>A | p.Ala175Thr | missense_variant | Exon 6 of 28 | 5 | ENSP00000303540.4 | |||
SCN1A | ENST00000375405.7 | c.523G>A | p.Ala175Thr | missense_variant | Exon 4 of 26 | 5 | ENSP00000364554.3 | |||
SCN1A | ENST00000409050.1 | c.523G>A | p.Ala175Thr | missense_variant | Exon 4 of 26 | 5 | ENSP00000386312.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Early infantile epileptic encephalopathy with suppression bursts Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Ala175 amino acid residue in SCN1A. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 18930999). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has been observed in individual(s) with Dravet syndrome (PMID: 17347258, 19589774). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 68656). This variant is not present in population databases (ExAC no frequency). This sequence change replaces alanine with threonine at codon 175 of the SCN1A protein (p.Ala175Thr). The alanine residue is highly conserved and there is a small physicochemical difference between alanine and threonine. -
not provided Pathogenic:1
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This substitution is predicted to be within the transmembrane segment S2 of the first homologous domain; This variant is associated with the following publications: (PMID: 19589774, 23884151, 24136861, 35074891, 17347258, 18804930) -
Severe myoclonic epilepsy in infancy Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at